Cambridge Cognition Holdings plc announced the opening of a US office in Salt Lake City to meet the growing demand from both existing and new North American customers.

The company announced that the US office will be headed by former Baxter and Myriad executive Bill Rusconi and will support the continuing use of Cantab as the leading cognitive assessments in both pharmaceutical clinical trials and academic research but also increase the global reach of the company's emerging healthcare technology division.